Day: April 29, 2026

Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Snapshot Recipes Redesign with Advanced AI, Beverage Integration, and Smart Cookbook Features

Staff April 29, 2026

MESA, AZ / ACCESS Newswire / April 29, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced a...

Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

Staff April 29, 2026

Doheny scientists, clinician-scientists, and research fellows will present findings on eye disease, advanced imaging, artificial intelligence and more at the...

Codexis to share RNA manufacturing advances at TIDES USA

Staff April 29, 2026

REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for...

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

Staff April 29, 2026

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven...

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Staff April 29, 2026

THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...

RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET

Staff April 29, 2026

MOUNTAIN VIEW, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences...

Imviva Biotech to Present Clinical Data from Ongoing Phase 1/2 Study of CTA313 at the American Society of Gene & Cell Therapy’s Annual Meeting

Staff April 29, 2026

Dual-targeted allogeneic CAR-T therapy demonstrates immune-reset mechanism and durable remission in system lupus erythematosusBOSTON, April 29, 2026 (GLOBE NEWSWIRE) --...

TOMI Environmental Solutions Targets $70 Billion U.S. Drone and Defense Budget with Autonomous SteraMist iHP Decontamination

Staff April 29, 2026

Strategic Initiative Focuses on Automated Biological and Chemical Defense for Land, Air, Sea, and SpaceFREDERICK, Md., April 29, 2026 (GLOBE...

Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias

Staff April 29, 2026

SAN FRANCISCO, April 29, 2026 (GLOBE NEWSWIRE) -- Laguna Biotherapeutics, Inc. (Laguna), a clinical-stage biotechnology company focused on novel live...

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate “Two-Lens” Growth Strategy

Staff April 29, 2026

Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role...

Akanda Adjourns Special Meeting of Shareholders

Staff April 29, 2026

Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today convened and subsequently...

Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

Staff April 29, 2026

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference,...

GAT Sport Introduces Nitraflex(R) Performance Pre-Workout Chews, a Breakthrough Format Designed to Reignite the Pre-Workout Category

Staff April 29, 2026

Patent-Pending Chewable Delivery Technology Offers Powder-Level Performance With Unmatched Convenience MONROE, CT / ACCESS Newswire / April 29, 2026 /...

Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market

Staff April 29, 2026

Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026RICHMOND, Calif.,...

KeepWOL Announces Expansion Into Healthcare Following Clinical Collaboration With Academic Medical Center

Staff April 29, 2026

AI-Powered Platform Supports Physician-Led Initiative To Strengthen Belonging And Team Performance Across Clinical Workforce SCOTTSDALE, AZ / ACCESS Newswire /...

Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer

Staff April 29, 2026

EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA submission in Q4 2026...

Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event Titled “From FDA Wins to Scaling Manufacturing – What Investors Should Watch.” Featuring Modular Medical CEO – Friday, May 1, 2026

Staff April 29, 2026

Meet with Modular Medical CEO Jeb BesserThere are 4.8 million individuals with diabetes in the US that require daily insulin....

CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™ into Gynecology

Staff April 29, 2026

PRESS RELEASE Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On...

Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

Staff April 29, 2026

Company Advances Towards Full FDA Approval of Crofelemer for Chemotherapy-Induced Diarrhea SAN FRANCISCO, CA / ACCESS Newswire / April 29,...

Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting

Staff April 29, 2026

LONDON and CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a...

You may have missed